Molecular Evidence of Sexual Transmission of Ebola Virus.

A suspected case of sexual transmission from a male survivor of Ebola virus disease (EVD) to his female partner (the patient in this report) occurred in Liberia in March 2015. Ebola virus (EBOV) genomes assembled from blood samples from the patient and a semen sample from the survivor were consistent with direct transmission. The genomes shared three substitutions that were absent from all other Western African EBOV sequences and that were distinct from the last documented transmission chain in Liberia before this case. Combined with epidemiologic data, the genomic analysis provides evidence of sexual transmission of EBOV and evidence of the persistence of infective EBOV in semen for 179 days or more after the onset of EVD. (Funded by the Defense Threat Reduction Agency and others.).

[1]  Rachel S. G. Sealfon,et al.  Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak , 2014, Science.

[2]  Claudia Kohl,et al.  Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa , 2015, Nature.

[3]  Possible Sexual Transmission of Ebola Virus — Liberia, 2015 , 2015, MMWR. Morbidity and mortality weekly report.

[4]  Trevor Bedford,et al.  Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone , 2015, Cell.

[5]  G. Martini,et al.  [Spermatogenic transmission of the "Marburg virus". (Causes of "Marburg simian disease")]. , 1968, Klinische Wochenschrift.

[6]  S. Dowell,et al.  Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. , 2007, The Journal of infectious diseases.

[7]  Stephan Günther,et al.  Emergence of Zaire Ebola virus disease in Guinea. , 2014, The New England journal of medicine.

[8]  Rachel S. G. Sealfon,et al.  Nomenclature- and Database-Compatible Names for the Two Ebola Virus Variants that Emerged in Guinea and the Democratic Republic of the Congo in 2014 , 2014, Viruses.

[9]  A. Sanchez,et al.  Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. , 1999, The Journal of infectious diseases.

[10]  K. C. Zoon,et al.  Mutation rate and genotype variation of Ebola virus from Mali case sequences , 2015, Science.

[11]  J Bertolli,et al.  Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. , 1999, The Journal of infectious diseases.

[12]  R. Swanepoel,et al.  Unexpected Ebola virus in a tertiary setting: Clinical and epidemiologic aspects , 2000, Critical care medicine.

[13]  Di Liu,et al.  Genetic diversity and evolutionary dynamics of Ebola virus in Sierra Leone , 2015, Nature.

[14]  Christopher Dye,et al.  Controlling the Last Known Cluster of Ebola Virus Disease — Liberia, January–February 2015 , 2015, MMWR. Morbidity and mortality weekly report.

[15]  Pardis C Sabeti,et al.  Distinct lineages of Ebola virus in Guinea during the 2014 West African epidemic , 2015, Nature.

[16]  G. Olinger,et al.  Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. , 2015, The Lancet. Infectious diseases.

[17]  G. Lloyd,et al.  A case of Ebola virus infection. , 1977, British medical journal.

[18]  Thierry Cordier-Lassalle.  Summary of sector response model A quality management system that led to Liberia ’ s success in fighting Ebola , 2015 .

[19]  Pardis C. Sabeti,et al.  Monitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in Liberia , 2015, Emerging infectious diseases.

[20]  Justine R. Smith,et al.  Persistence of Ebola Virus in Ocular Fluid during Convalescence. , 2015, The New England journal of medicine.